AAPL   396.75 (+3.41%)
MSFT   215.08 (+0.66%)
FB   248.71 (+1.49%)
GOOGL   1,567.78 (+1.87%)
AMZN   3,293.06 (+2.91%)
TSLA   1,712.71 (+10.88%)
AMD   56.74 (+1.54%)
F   6.16 (+0.98%)
GILD   77.81 (+1.95%)
DIS   119.55 (+0.18%)
NFLX   564.57 (+2.89%)
BAC   24.13 (+0.46%)
BA   180.29 (+1.04%)
AAPL   396.75 (+3.41%)
MSFT   215.08 (+0.66%)
FB   248.71 (+1.49%)
GOOGL   1,567.78 (+1.87%)
AMZN   3,293.06 (+2.91%)
TSLA   1,712.71 (+10.88%)
AMD   56.74 (+1.54%)
F   6.16 (+0.98%)
GILD   77.81 (+1.95%)
DIS   119.55 (+0.18%)
NFLX   564.57 (+2.89%)
BAC   24.13 (+0.46%)
BA   180.29 (+1.04%)
AAPL   396.75 (+3.41%)
MSFT   215.08 (+0.66%)
FB   248.71 (+1.49%)
GOOGL   1,567.78 (+1.87%)
AMZN   3,293.06 (+2.91%)
TSLA   1,712.71 (+10.88%)
AMD   56.74 (+1.54%)
F   6.16 (+0.98%)
GILD   77.81 (+1.95%)
DIS   119.55 (+0.18%)
NFLX   564.57 (+2.89%)
BAC   24.13 (+0.46%)
BA   180.29 (+1.04%)
AAPL   396.75 (+3.41%)
MSFT   215.08 (+0.66%)
FB   248.71 (+1.49%)
GOOGL   1,567.78 (+1.87%)
AMZN   3,293.06 (+2.91%)
TSLA   1,712.71 (+10.88%)
AMD   56.74 (+1.54%)
F   6.16 (+0.98%)
GILD   77.81 (+1.95%)
DIS   119.55 (+0.18%)
NFLX   564.57 (+2.89%)
BAC   24.13 (+0.46%)
BA   180.29 (+1.04%)
Log in

LON:YGENYourgene Health Share Price, Forecast & News

GBX 16.50
0.00 (0.00 %)
(As of 07/13/2020 05:29 AM ET)
Add
Compare
Today's Range
16
Now: GBX 16.50
16.50
50-Day Range
16.50
MA: GBX 17.77
19.81
52-Week Range
7
Now: GBX 16.50
24.55
Volume424,157 shs
Average VolumeN/A
Market Capitalization£103.01 million
P/E Ratio15.00
Dividend YieldN/A
BetaN/A
Yourgene Health Plc, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. The company is headquartered in Manchester, the United Kingdom.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.63 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone44 16 1667 6865

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£12.71 million
Cash FlowGBX 0.70 per share
Book ValueGBX 3.90 per share

Profitability

Miscellaneous

Employees91
Market Cap£103.01 million
Next Earnings DateN/A
OptionableNot Optionable

Receive YGEN News and Ratings via Email

Sign-up to receive the latest news and ratings for YGEN and its competitors with MarketBeat's FREE daily newsletter.

Yourgene Health (LON:YGEN) Frequently Asked Questions

How has Yourgene Health's stock been impacted by COVID-19 (Coronavirus)?

Yourgene Health's stock was trading at GBX 14.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, YGEN stock has increased by 11.9% and is now trading at GBX 16.50. View which stocks have been most impacted by Coronavirus.

Has Yourgene Health been receiving favorable news coverage?

Media stories about YGEN stock have trended very negative recently, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Yourgene Health earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Yourgene Health.

Who are some of Yourgene Health's key competitors?

What other stocks do shareholders of Yourgene Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Yourgene Health investors own include Air Liquide (AI), Concepta (CPT), Amryt Pharma (AMYT), Altyn (ALTN), Alio Gold (ALO), Alamos Gold (AGI), African Gold Group (AGG), Aminex (AEX), Agnico Eagle Mines (AEM) and Ariana Resources (AAU).

Who are Yourgene Health's key executives?

Yourgene Health's management team includes the following people:
  • Dr. Stephen Little, Exec. Vice Chairman (Age 62)
  • Mr. Barry Hextall, CFO, Sec. & Exec. Director
  • Dr. Chia-Han Chan, Chief Scientific Officer & Director (Age 43)
  • Mr. Lyn Fafydd Rees, CEO & Director (Age 46)
  • Mr. Hayden Jeffreys, COO & Director (Age 44)

What is Yourgene Health's stock symbol?

Yourgene Health trades on the London Stock Exchange (LON) under the ticker symbol "YGEN."

How do I buy shares of Yourgene Health?

Shares of YGEN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Yourgene Health's stock price today?

One share of YGEN stock can currently be purchased for approximately GBX 16.50.

How big of a company is Yourgene Health?

Yourgene Health has a market capitalization of £103.01 million and generates £12.71 million in revenue each year. Yourgene Health employs 91 workers across the globe.

What is Yourgene Health's official website?

The official website for Yourgene Health is www.yourgene-health.com.

How can I contact Yourgene Health?

The company can be reached via phone at 44 16 1667 6865.

This page was last updated on 7/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.